Microbot Medical Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: MBOT · Form: 8-K · Filed: Oct 7, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $2.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
Related Tickers: MBOT
TL;DR
Microbot Medical (MBOT) filed an 8-K on 10/6/25 detailing a material definitive agreement and equity sales.
AI Summary
Microbot Medical Inc. announced on October 6, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for Microbot Medical Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- October 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19871 (filing_id) — Commission File Number
- 94-3078125 (ein) — IRS Employer Identification No.
- 175 Derby St. , Bld. 27 Hingham , MA 02043 (address) — Address of Principal Executive Offices
FAQ
What type of material definitive agreement did Microbot Medical Inc. enter into?
The filing states that Microbot Medical Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on October 6, 2025.
What are the principal executive offices of Microbot Medical Inc.?
The principal executive offices of Microbot Medical Inc. are located at 175 Derby St., Bld. 27 Hingham, MA 02043.
What is the Commission File Number for Microbot Medical Inc.?
The Commission File Number for Microbot Medical Inc. is 000-19871.
What other types of events are reported in this 8-K filing besides the material agreement?
In addition to the material definitive agreement, the filing also reports on unregistered sales of equity securities and other events.
Filing Stats: 835 words · 3 min read · ~3 pages · Grade level 10.4 · Accepted 2025-10-07 08:15:19
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $2.10 — Common Stock"), at an exercise price of $2.10 per share, and the Holder received 1,32
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 25KB
- 0001493152-25-017212.txt ( ) — 263KB
- mbot-20251006.xsd (EX-101.SCH) — 3KB
- mbot-20251006_lab.xml (EX-101.LAB) — 33KB
- mbot-20251006_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: October 7, 2025